Barrow, Colin J. and Micheal G. Zagorskig (1991) “Solution Structures of β Peptide and Its Constituent Fragments: Relation to Amyloid Deposition” Science 253: 179-182. |
Barrow, Colin J. et al. (1992) “Solution Conformations and Aggregational Properties of Synthetic Amyloid β-Peptides of Alzheimer's Disease: Analysis of Circular Dichroism Spectra” J. Mol. Biol. 225:1075-1093. |
Brown, Abraham M. et al. (1994) “Biotinylated and Cysteine-Modified Peptides as Useful Reagents for Studying the Inhibition of Cathepsin G” Analytical Biochemistry 217: 139-147. |
Burdick, Debra et al. (1992) “Assembly and Aggregation Properties of Synthetic Alzheimer's A4/β Amyloid Peptide Analogs” Journal of Biological Chemistry 267(1):546-554. |
Chantry, Andrew et al. (1992) “Biotinyl Analogues of Amylin as Biologically Active Probes for Amylin/CGRP Receptor Recognition” FEBS 296(2):123-127. |
Clemens, James A. and Diane T. Stephenson (1992) “Implants Containing β-Amyloid Protein Are Not Neurotoxic to Young and Old Rat Brain” Neurobiology of Aging 13:581-586. |
Clements, Angela et al. (1993) “Aggregation of Alzheimer's Peptides” Biochemical Society Transactions 22: 16S. |
Come, Jon H. et al. (1993) “A Kinetic Model for Amyloid Formation in the Prion Diseases: Importance of Seeding” Proc. Natl. Acad. Sci. USA 90: 5959-5963. |
Evans, Krista C. et al. (1995) “Apolipoprotein E Is a Kinetic But Not a Thermodynamcic Inhibitor of Amyloid Formation: Implications for the Pathogenesis and Treatment of Alzheimer Disease” Proc. Natl. Acad. Sci. USA 92:763-767. |
Fabian, Heinz et al. (1993) “Comparative Analysis of Human and Dutch-Type Alzheimer β-Amyloid Peptides by Infrared Spectroscopy and Circular Dichroism” Biochemical and Biophysical Research Communications 191(1):232-239. |
Fabian, Heinz et al. (1994) “Synthetic Post-Translationally Modified Human Aβ Peptide Exhibits a Markedly Increased Tendency to Form β-Pleated Sheets in vitro” Eur. J. Biochem. 221:959-964. |
Findeis, Mark A. et al. (1999) “Modified-Peptide Inhibitors of Amyloid β-Peptide Polymerization” Biochemistry 38:6791-6800. |
Flood, James F. et al. (1994) “Topography of a Binding Site for Small Amnestic Peptides Deduced from Structure-activity Studies: Relation to Amnestic Effect of Amyloid β Protein,” Proc. Natl. Acad. Sci. USA 91:380-4. |
Fraser, P.E. et al. (1994) “Conformation and Fibrillogenesis of Alzheimer Aβ Peptides with Selected Substitution of Charged Residues” J. Mol. Biol. 244:64-73. |
Fraser, Paul E. et al. (1992) “Fibril Formation by Primate, Rodent, and Dutch-Hemorrhagic Analogues by Alzheimer Amyloid β-Protein” Biochemistry 31:10716-10723. |
Gorevic, P.D. et al. (1987) “Ten to Fourteen Residue Peptides of Alzheimer's Disease Protein are Sufficient for Amyloid Fibril Formation and Its Characteristic Xray Diffraction Pattern” Biochemical and Biophysical Research Communications 147(2):854-862. |
Gowing, Eric et al. (1994) “Chemical Characterization of Aβ 17-42 Peptide, a Component of Diffuse Amyloid Deposits of Alzheimer Disease” J. Biol. Chem. 269(15):10987-10990. |
Halverson, Kurt et al. (1990) “Molecular Determinants of Amyloid Deposition in Alzheimer's Disease: Conformational Studies of Synthetic β-Protein Fragments” Biochemistry 29(11):2639-2644. |
Hansen, Morten B. et al. (1989) “Re-examination and Further Development of a Precise and Rapid Dye Method for Measuring Cell Growth/Cell Kill” J. Immunol. Meth. 119:203-210. |
Hardy, John A. and Gerald A. Higgins (1992) “Alzheimer's Disease: The Amyloid Cascade Hypothesis” Science 256:184-185. |
Hendrix, Julia et al. (1992) “A Convergent Synthesis of the Amyloid Protein of Alzheimer's Disease” J. Am. Chem. Soc. 114: 7930-7931. |
Hilbich, Caroline et al. (1991) “Aggregation and Secondary Structure of Synthetic Amyloid βA4 Peptides of Alzheimer's Disease” J. Mol. Biol. 218:149-163. |
Hilbich, Caroline et al. (1991) “Human and Rodent Sequence Analogs of Alzheimer's Amyloid βA4 Share Similar Properties and Can Be Solubilized in Buffer of pH 7.4” Eur. J. Biochem. 201:61-69. |
Hilibich, Caroline et al. (1992) “Substitutions of Hydrophobic Amino Acids Reduce the Amyloidogenicity of Alzheimer's Disease βA4 Peptides” J. Mol. Biol. 228:460-473. |
Inouye, H. et al. (1993) “Structure of β-Crystallite Assemblies Formed by Alzheimer β-Amyloid Protein Analogues: Analysis by X-ray Diffraction,” Biophys. J. 64:502-19. |
Isowa, Yoshikazu et al. (1977) “The Synthesis of Peptides of Means of Proteolytic Enzymes” Bulletin of the Chemical Society of Japan 50:2762-2765. |
Jarrett, Joseph T. and Peter T. Lansbury, Jr. (1993) “Seeding ‘One-Dimensional Crystallization’ of Amyloid: A Pathogenic Mechanism in Alzheimer's Disease and Scrapie?” Cell 73:1055-1058. |
Jarrett, Joseph T. et al. (1993) “The Carboxy Terminus of the β Amyloid Protein Is Critical for the Seeding of Amyloid Formation: Implications for the Pathogenesis of Alzheimer's Disease” Biochemistry 32(18):4693-4697. |
Jarrett, Joseph T. et al. (1994) “Models of the β Protein C-Terminus: Differences in Amyloid Structure May Lead to Segregation of ‘Long’ and ‘Short’ Fibrils” Journals of the American Chemical Society 116(21):9741-9742. |
Katakai, Ryoichi (1977) “Sequential Polypeptides: The Steric Hindrance of L-Valine Residues in the Polycondensation of Peptide Active Esters” Bulletin of the Chemical Society of Japan 50(5): 1173-1178. |
Kelly, Jeffery W. and Peter T. Lansbury, Jr. (1994) “A Chemical Approach to Elucidate the Mechanism of Transthyretin and β-Protein Amyloid Fibril Formation” INt. J. Exp. Clin. Invest 1:186-205. |
Kirschner, Daniel A. et al. (1987) “Synthetic Peptide Homologous to β Protein from Alzheimer Disease forms Amyloid-like Fibrils in vitro” Proc. Natl. Acad. Sci. USA 84:6953-6957. |
Klunk, William E. and Jay W. Pettegrew (1990) “Alzheimer's β-Amyloid Protein Is Covalently Modified When Dissolved in Formic Acid” Journal of Neurochemistry 54(6):2050-2054. |
Koudinov, Alexei (1994) “The Soluble Form of Alzheimer's Amyloid Beta Protein is Complexed to High Density Lipoprotein 3 and Very High Density Lipoprotein in Normal Human Plasma” Biochemical and Biophysical Research Communications 205(2):1164-1171. |
Lansbury, Jr., Peter T. (1992) “In Pursuit of the Molecular Structure of Amyloid Plaque: New Technology Provides Unexpected and Critical Information” Biochemistry 31(30):6866-6870. |
LeVine, III, Harry (1993) “Thioflavine T Interactions with Synthetic Alzheimer's Disease β-Amyloid Peptides: Detection of Amyloid Aggregation in Solution” Protein Science 2: 404-410. |
Maggio, John E. et al. (1992) “Reversible in vitro Growth of Alzheimer Disease β-Amyloid Plaques by Deposition of Labeled Amyloid Peptide” Proc. Natl. Acad. Sci. USA 89:5462-5466. |
Miller, Brian T. et al. (1994) “Identification and Characterization of O-Biotinylated Hydroxy Amino Acid Residues in Peptides” Analytical Biochemistry 219:240-248. |
Orlando, Ron et al. (1992) “Covalent Modification of Alzheimer's Amyloid β-Peptide in Formic Acid Solutions” Biochemical and Biophysical Research Communications 184(2):686-691. |
Pike, Christian J. et al. (1993) “Neurodegeneration Induced by β-Amyloid Peptides in vitro: The Role of Peptide Assembly State” Journal of Neuroscience 13(4):1676-1687. |
Pike, Christian J. et al. (1995) “Structure-Activity Analyses of β-Amyloid Peptides: Contributions of the β25-35 Region to Aggregation and Neurotoxicity” Journal of Neurochemistry 64(1):253-265. |
Saito, Yasunari et al. (1995) “Vector-mediated Delivery of 125I-labeled B-amyloid Peptide Aβ 1-40 Through the Blood-brain Barrier and Binding to Alzheimer disease Amyloid of the AB1-40/Vector Complex” Proc. Natl. Acad. Sci. USA vol. 91:10227-10231. |
Schwarzman, Alexander L. et al. (1994) “Transthyretin Sequesters Amyloid β Protein and Prevents Amyloid Formation” Proc. Natl. Acad. Sci. USA 91:8368-8372. |
Shearman, Mark S. et al. (1994) “Inhibition of PC12 Cell Redox Activity is a Specific, Early Indicator of the Mechanism of β-Amyloid-Mediated Cell Death” Proc. Natl. Acad. Sci. USA 91:1470-1474. |
Shen, Chih-Lung et al. (1994) “Effect of Acid Predissolution of Fibril Size and Fibril Flexibility of Synthetic β-Amyloid Peptide” Biophysical Journal 67:1238-1246. |
Shen, Chih-Lung et al. (1993) “Light Scattering Analysis of Fibril Growth from the Amino-Terminal Fragment β(1-28) of β-Amyloid Peptide” Biophysical Journal 65:2383-2395. |
Snyder, Seth W. et al. (1994) “Amyloid-β Aggregation: Selective Inhibition of Aggregation in Mixtures of Amyloid with Different Chain Lengths” Biophysical Journal 67:1216-1228. |
Sonnenberg-Reines, J. et al. (1993) “Biotinylated and Cysteine Modified Peptides as Useful Reagents for Studying the Inhibition of Putative N-terminal B-Amyloid Peptide Enzymes,” Society for Neuroscience Abstracts 19:861. |
Soreghan, Brian et al. (1994) “Surfactant Properties of Alzheimer's Aβ Peptides and the Mechanism of Amyloid Aggregation” The Journal of Biological Chemistry 269(46):28551-28554. |
Sorimachi, Kay and David J. Craik (1994) “Structure Determination of Extracellular Fragments of Amyloid Proteins Involved in Alzheimer's Disease and Dutch-type Hereditary Cerebral Haemorrhage with Amyloidosis” Eur. J. Biochem 219:237-251. |
Soto, Claudio et al. (1996) “Inhibition of Alzheimer's Amyloidosis by Peptides that Prevents β-Sheet Conformation,” Biochemical and Biophysical Research Communications 226:672-80. |
Strittmatter, Warren J. et al. (1993) “Binding of Human Apolipoprotein E to Synthetic Amyloid β Peptide: Isoform-Specific Effects and Implications for Late-Onset Alzheimer Disease” Proc. Natl. Acad. Sci. USA 90:8098-8102. |
Tjernberg, Lars O. et al. (1996) “Arrest of β-Amyloid Fibril Formation by a Pentapeptide Ligand,” The Journal of Biological Chemistry 271(15):8545-8. |
Tjernberg, Lars O. et al. (1997) “Controlling Amyloid β-Peptide Fibril Formation with Protease-stable Ligands,” The Journal of Biological Chemistry 272(19):12601-6. |
Tomiyama, Takami et al. (1994) “Racemization of Asp23 Residue Affects the Aggregation Properties of Alzheimer Amyloid β Protein Analogues” J. Biol. Chem. 269(14):10205-10208. |
Tomski, Sharon J. and Regina M. Murphy (1992) “Kinetics of Aggregation of Synthetic β-Amyloid Peptide” Archives of Biochemistry and Biophysics 294(2):630-638. |
Vitek, Michael P. et al. (1994) “Advanced Glycation End Products Contribute to Amyloidosis in Alzheimer Disease” Proc. Natl. Acad. Sci. USA 91:4766-4770. |
Vogler, K. et al. (1965) “Synthese von All-D-Val5-Angiotensin il-Asp1-β-Amid1),” Helv. Chim. Acta. 48(152):1407-14. |
Vogler, K. et al. (1966) “Synthesen von Bradykinin-Analogen mit D-Aminosäuren (all-D-Bradykinin und all-D-retro-Bradikinin1)2),” Helv. Chim. Acta. 49(43):390-403. |
Vyas, S. B. et al. (1992) “Characterization of Aggregation in Alzheimer β-protein Using Synthetic Peptide Fragments on Reverse-Phase Matrix,” in Peptides, Chemistry and Biology (J.A. Smith and J.E. Rivier, eds.), ESCOM, Leiden, 278-279. |
Weinreb, Paul H. et al. (1994) “Peptide Models of a Hydrophobic Cluster at the C-Terminus of the β-Amyloid Protein” Journal of the American Chemical Society 116(23):10835-10836. |
Wood, Stephen J. et al. (1995) “Prolines and Amyloidogenicity in Fragments of the Alzheimer's Peptide β/A4,” Biochemistry 34:724-30. |